Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

NCT04557449

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +33 more
Locations
  • Ellison Institute Los Angeles, California, United States
  • Smilow Cancer Hospital at Yale - New Haven New Haven, Connecticut, United States
  • Yale-New Haven Hospital-Yale Cancer Center New Haven, Connecticut, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

NCT03563248

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

NCT03785249

Conditions
Advanced Cancer, Colonic Diseases, Colonic Neoplasms, +20 more
Locations
  • Local Institution - 001-826 Birmingham, Alabama, United States
  • Local Institution - 001-965 Anchorage, Alaska, United States
  • Local Institution - 001-821 Phoenix, Arizona, United States
  • Local Institution - 001-873-A Tucson, Arizona, United States
View all 222 locations
View Trial Details
Active, Not Recruiting

Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease

NCT04595266

Conditions
Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +10 more
Locations
  • Hospital Clínic Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • H. Univ. Ramón y Cajal Madrid, Spain
View Trial Details
Active, Not Recruiting

Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma

NCT02505750

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Clinique de la Sauvegarde Lyon, Auvergne-Rhône-Alpes, France
  • CHRU Besançon Besançon, Bourgogne-Franche-Comté, France
  • Centre Jean Godinot Reims, Champagne-Ardenne, France
  • Centre Léon Bérard Lyon, France
View all 18 locations
View Trial Details

Related conditions